SARS-CoV-2-specific CD8+ TRM cells were found in the oropharyngeal lymphoid tissue of children and adults unexposed to COVID-19, which were functionally weaker than EBV-specific CD8+ TRM cells, possibly spearheading an early immune response. The gene discussed is CD8A; the disease is COVID-19.